Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMandarin In.sg Regulatory News (MDO)

  • This share is currently suspended. It was suspended at a price of 1.65
  • There is currently no data for MDO

Interim Management Statement

18 May 2023 10:23

RNS Number : 8917Z
Mandarin Oriental International Ltd
18 May 2023
 

Announcement

 

The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

 

18th May 2023 - Mandarin Oriental International Limited today issues its Interim Management Statement for the first quarter of 2023.

 

The Group recorded an underlying profit in the first quarter of 2023, driven by improved performance from both the Group's owned hotels and its management business. RevPAR grew substantially in Asia compared to last year, as the region benefitted from the removal of travel restrictions. As a result, the Group's owned hotels saw a significantly improved performance, particularly in Hong Kong, Tokyo, and Bangkok. In the rest of the world, our hotels were also able to achieve a higher RevPAR compared to both last year and 2019, driven by strong rates.

 

The first quarter saw progress on a number of hotel developments. In January, the Group announced a new management contract for a luxury beach resort in Mallorca, Spain, scheduled to open by the end of 2024. In February, after three years' work, the Emirates Palace hotel in Abu Dhabi was rebranded as Emirates Palace Mandarin Oriental, Abu Dhabi. In March, Mandarin Oriental, Singapore, closed for a substantial renovation; it is expected to reopen in September 2023.

 

As a result of improved trading conditions, the Group generated underlying earnings before interest, tax, depreciation, and amortisation ('EBITDA') of US$30 million, a substantial increase from the EBITDA loss of US$1 million in the first quarter of 2022. Owned hotels reported an EBITDA of US$19 million, with almost all hotels delivering increased financial performance. The management business saw significant growth and generated higher fees, with hotels, particularly in Hong Kong and Mainland China, contributing to an EBITDA of US$7 million. Unaudited underlying profit in the first quarter was US$3 million, much improved from an underlying loss of US$26 million in 2022.

 

The Group's redevelopment project in Causeway Bay, Hong Kong, formerly the site of The Excelsior hotel, is ongoing, in line with our budget, and is expected to complete in early 2025.

 

Consolidated net debt as at 31st March 2023 reduced to US$311 million (US$376 million at 31st December 2022). The Group's liquidity position remains robust, with US$453 million in available committed debt facilities and US$306 million of cash reserves. Gearing was 6% of adjusted shareholders' funds.

 

On 2nd May 2023, the Company announced that Laurent Kleitman would replace James Riley as Group Chief Executive of Mandarin Oriental International Limited with effect from 1st September 2023.

 

Mandarin Oriental International Limited is incorporated in Bermuda and has a primary listing in the standard segment of the London Stock Exchange, with secondary listings in Bermuda and Singapore. Mandarin Oriental is a member of the Jardine Matheson Group.

 

- end -

 

For further information, please contact:

 

Mandarin Oriental Hotel Group International Limited

James Riley

(852) 2895 9288

Matthew Bishop

(852) 2895 9288

 

Brunswick Group Limited

William Brocklehurst

(852) 5685 9881

 

This and other Group announcements can be accessed online at 'www.mandarinoriental.com'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCKVLBFXELLBBB
Date   Source Headline
6th Mar 20149:51 amRNSPublication of Shareholder Circular
6th Mar 20149:17 amRNSFinal Results
6th Mar 20149:10 amRNSPropose Transfer of Listing Segment
10th Feb 20149:21 amRNSNotice of 2013 Final Results
31st Dec 20138:01 amRNSTotal Voting Rights
29th Nov 20139:58 amRNSTotal Voting Rights
6th Nov 20139:10 amRNSInterim Management Statement
31st Oct 201311:18 amRNSTotal Voting Rights
2nd Oct 201310:21 amRNSDividend
30th Sep 201310:13 amRNSTotal Voting Rights
25th Sep 201310:18 amRNSBlocklisting Interim Review
10th Sep 201310:54 amRNSDirector/PDMR Shareholding
2nd Sep 201312:19 pmRNSDirector/PDMR Shareholding
1st Aug 201310:06 amRNSHalf Yearly Report
4th Jul 201310:42 amRNSNotice of 2013 Half-Yearly Results
2nd Jul 201310:24 amRNSTotal Voting Rights
31st May 201310:43 amRNSTotal Voting Rights
31st May 201310:42 amRNSDirector Declaration
15th May 20133:27 pmRNSResult of AGM
15th May 20132:15 pmRNSResult of AGM
15th May 201312:35 pmRNSInterim Management Statement
8th May 201310:25 amRNSDividend
30th Apr 201312:05 pmRNSDirector Declaration
15th Apr 201310:14 amRNSAnnual Financial Report
2nd Apr 201310:54 amRNSTotal Voting Rights
27th Mar 20139:40 amRNSDirector Declaration
25th Mar 201310:13 amRNSBlocklisting Interim Review
20th Mar 20138:44 amRNSAdditional Listing
19th Mar 201310:45 amRNSDirector/PDMR Shareholding
18th Mar 201311:21 amRNSDirector/PDMR Shareholding
13th Mar 201312:01 pmRNSDirector/PDMR Shareholding
12th Mar 201311:33 amRNSDirector/PDMR Shareholding
7th Mar 20139:14 amRNSChairmanship
7th Mar 20139:06 amRNSFinal Results
8th Feb 201312:43 pmRNSAcquisition of Freehold of Paris Hotel Completed
8th Feb 20139:13 amRNSNotice of 2012 Final Results
31st Jan 20133:43 pmRNSResults of Special General Meeting
23rd Jan 201312:14 pmRNSDirectorate Change and Declaration
6th Dec 20129:18 amRNSDirectorate Change
29th Nov 20126:02 pmRNSAcquisition of Option to Purchase Freehold
7th Nov 20129:10 amRNSInterim Management Statement
26th Sep 201210:22 amRNSDividend
25th Sep 201210:12 amRNSBlocklisting Interim Review
26th Jul 201210:06 amRNSHalf Yearly Report
29th Jun 201210:08 amRNSTotal Voting Rights
28th Jun 201212:45 pmRNSNotice of 2012 Half-Yearly Results
14th Jun 201211:51 amRNSDirector/PDMR Shareholding
11th Jun 201210:17 amRNSDirector Declaration
9th May 20122:35 pmRNSAGM Statement
9th May 20122:05 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.